Tandem Diabetes Care wins Health Canada approval for expanded insulin pump use

TNDM•2026-11-12

Health Canada approved expanded use of Tandem Diabetes Care’s t:slim X2 insulin pump with Control-IQ+ technology for type 1 diabetes during pregnancy, adults with type 2 diabetes and compatibility with Abbott’s FreeStyle Libre 3 Plus Sensor. The expanded indications and sensor compatibility are expected to become available in the second quarter of 2027.

Tandem Diabetes Care wins Health Canada approval for expanded insulin pump use

1. Expanded approval

Related News

MetaVia's DA-1726 significantly reduces uric acid levels in Phase 1 trial

US tech salaries rise 2.1% year over year, Kelly's Motion Recruitment finds

Vessel on fire after being struck off UAE's Ras Al-Khaimah, maritime agencies say

OneWater Marine extends term loan and floor plan facility to 2029

SOLV Energy 3Q26 net income jumps 75% year over year to $122.75 million